Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Bright half for PharmaZen

For Immediate Release


November 12 2008

Bright half for PharmaZen

Biotechnology company PharmaZen has announced a sharply improved first half with a profit of $202,000 after interest and depreciation on a turnover of $3.087 million, with further improvement likely over the rest of the year.

The half-year result to June 30 is in stark contrast to the loss of $313,000 for the same period in 2007 on a turnover of $2.263 million.

Shares in PharmaZen, which supplies animal and health products, are traded through the unregistered securities trading facility.

PharmaZen chief executive, Craig McIntosh, said that the result has been exceptionally pleasing in light of the strength of the New Zealand dollar during this period.

“With 85% of sales exported the high NZ dollar has been a major issue for us but despite that we have been able to come out of a very difficult period in good shape,” he said.

The company is also benefiting from a $1m investment in new plant and machinery that has greatly enhanced productivity.

“We have put a lot of effort into product development over the last 18 months and are encouraged by the progress made – in particular trial results for the newly developed hair care ingredient look very promising.”

PharmaZen trading division Waitaki Biosciences International in Christchurch manufactures a range of powder products extracted from a wide range of animal and marine sources. The range includes green-lipped mussel, shark cartilage, natural calcium and Chondroitin Sulphate. The products are used by other companies as a base for health products, mainly in the areas of bone health, joint health, immune and digestive support as well as hair care and cosmetic applications.

ENDS

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


FIRST Union: Do Shareholders Realise Marsden Point Conversion Could Cost More Than Half A Billion Dollars?

FIRST Union, the union representing workers at Refining NZ, are querying whether shareholders voting on Friday on whether to convert the Marsden Point refinery to an import-only terminal realise the conversion could cost $650-700 million dollars... More>>



Civil Contractors: Massive Rebound In Civil Construction Business Confidence

New Zealand’s civil construction industry is riding a massive rebound in post-pandemic business confidence – but this may be undermined by skills shortages, which continue to be the industry’s number one challenge... More>>



Energy: Feeling Our Way Towards Hydrogen - Tina Schirr

Right now hydrogen is getting a lot of attention. Many countries are focusing on producing hydrogen for fuel, or procuring it, or planning for its future use... More>>





ASB: New Support Finder Tool Helps Connect Customers With Thousands In Government Support

ASB research alongside benefit numbers from the Ministry of Social Development shows an increased number of Kiwis are struggling financially, and many may not be aware they’re eligible for government support... More>>


Housing: New Home Consents Continue To Break Records

A record 44,299 new homes were consented in the year ended June 2021, Stats NZ said today. “The annual number of new homes consented rose again in the June 2021 year, the fourth consecutive month of rises,” construction statistics manager Michael Heslop said... More>>


Real Estate: June Home Transfers Remain High
There were 44,517 home transfers in the June 2021 quarter, the highest June quarter figure since 2016, Stats NZ said today. The number of home transfers was very similar to the March 2021 quarter and was up 18,252 from the June 2020 quarter... More>>